Caroline Nievergelt

Has grant

Professor

University of California, San Diego
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

Next steps for PTSD genomics: from loci to function

Open Date: 2024-05-17

Close Date: 2029-03-31

Grant: Open

Genetics of PTSD in African Ancestry Populations

Open Date: 2023-08-25

Close Date: 2028-07-31

Grant: Close

Genetic Architecture of Tinnitus and its Relationship to Hearing Loss

Open Date: 2022-07-01

Close Date: 2026-06-30

Grant: Close

4/7 Psychiatric Genomics Consortium: Advancing Discovery and Impact

Open Date: 2021-04-10

Close Date: 2026-02-28

Grant: Open

Genomic Architecture of Functional Brain Networks in PTSD

Open Date: 2017-09-06

Close Date: 2026-12-31

Articles (6)

Chronic prostatitis/chronic pelvic pain syndrome is common, and it impacts men’s health and quality of life. The genetic basis of this condition remains largely unknown. Here, we conduct a GWAS using data from the Million Veteran Program of over 590,000 men of European, African, and Hispanic ancestry, including 14,575 chronic prostatitis/chronic pelvic pain syndrome cases. The multi-ancestry analysis identifies eight novel loci associated with chronic prostatitis/chronic pelvic pain syndrome risk, an increase from three significant genome-wide loci found in the European participants alone. We also estimate the genetic correlations between chronic prostatitis/chronic pelvic pain syndrome and 12 phenotypes. Notably, the genetic correlation between chronic prostatitis/chronic pelvic pain syndrome and prostate cancer is not significant. Further, Mendelian randomization shows a significant, potentially bidirectional causal relationship between chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia, but not between chronic prostatitis/chronic pelvic pain syndrome and prostate cancer, suggesting a complex interplay between chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Results of bivariate causal mixture modeling indicate that some of the same genetic variants likely contribute to the development of chronic prostatitis/chronic pelvic pain syndrome, benign prostatic hyperplasia, and prostate cancer.

Year:

2026

Migraine is a neurovascular disorder that poses a high burden to Veterans, who face a greater risk than sex-matched individuals in the general population. Genetic research on migraine in Veterans and its link to psychiatric comorbidities is limited. We present a meta-analysis of a genome-wide association study (GWAS) of migraine in a predominantly male sample of over 433,000 Veterans, including 87,859 cases, from the Million Veteran Program (MVP), identifying 49 genome-wide significant loci, with 36 novel to this study, of which 7 replicated in an independent prior GWAS (after Bonferroni correction for number of loci tested). Our analyses revealed 283 genes, including some newly associated with migraine: MAML3, CELF4, IRX1, ASXL1, SPOCD1, CXCL , and TLR4 . In silico analyses showed enrichment in brain and uterine tissues, which may reflect broader hormonal or neuroendocrine pathways. Compared to previous migraine GWAS, our results show minimal vascular tissue enrichment, potentially reflecting the sample composition, which was predominantly men and Veterans. Migraine SNP-based heritability was 10% for men and 16% for women, and several sex-specific loci were identified through sex-stratified analyses. Despite high genetic correlations with neuropsychiatric disorders – including post-traumatic stress disorder, depression, and traumatic brain injury – Mendelian randomization analyses found no causal links. Finally, we prioritized potential migraine drug targets, including losmapimod (which reduces production of toxic DUX4 protein) and TLR4 antagonists.

Year:

2025

Background Disabling age-related and noise-induced sensorineural hearing loss (SNHL) affects 5% of the global population and is associated with isolation, depression, cognitive decline, and dementia. SNHL is strongly heritable with a polygenic signature of common genetic variants conferring small risks individually, thus requiring very large studies to achieve statistical power in genome-wide association studies (GWAS). Methods We present the first report of a clinical SNHL GWAS in the Million Veteran Program (MVP) cohort. GWAS findings are examined separately within MVP (210,240 cases and 265,275 controls), including multi-ancestry analysis, then combined and contrasted with the United Kingdom Biobank (UKB) self-reported hearing loss study (87,056 cases and 163,333 controls). We perform functional mapping and annotation, gene prioritization, gene-based and gene-set analysis, and cochlear cell type enrichment, including human single-cell results, then compare our results to known hereditary hearing loss genes. Summary results are leveraged to characterize the genetic architecture of SNHL. Results Substantial genetic overlap is seen between MVP and UKB despite differences in phenotypes, demographics, and environmental exposures. Individual GWAS and meta-analyses identify 108 loci, including 54 loci containing novel prioritized genes and/or protein-coding genes. Significant gene ontology pathways include “sensory perception of mechanical stimulus,” “ear development,” “actin-binding,” and “cytoskeletal protein binding,” indicative of mechanosensory structure and function in the cochlea. GWAS and gene-based analyses implicate 17 known familial hearing loss genes, expressing proteins in regions of hair cells, Type 1 neurons, stria vascularis, and subcellular regions of stereociliae, rootlets, and notably, mechanoelectrical transduction tip-links. Although risk for polygenic SNHL is predominantly captured by SNPs outside of congenital HHL genes (HHL), SNP-based partitioned heritability estimates show a 3.26-fold enrichment of HHL relative to other genes. Conclusion In the largest GWAS to date, combining clinical diagnosis of hearing loss and self-report data from two cohorts, we identify 108 loci with 54 novel genes. Despite the increased enrichment of HHL genes, 97% of the risk for adult SNHL is captured by SNPs outside of HHL genes. Although SNHL in the UKB and MVP were assessed using different phenotypes, genetic signals between the two cohorts are predominantly shared, and locus discovery is boosted through increased sample size in meta-analysis.

Year:

2025

Importance Biomarkers can potentially improve the diagnosis, monitoring, and treatment of posttraumatic stress disorder (PTSD). However, PTSD biomarkers that are scalable and easily integrated into real-world clinical settings have not been identified. Objective To triangulate phenotypic and genomic evidence from a health system biobank with a goal of identifying scalable and clinically relevant biomarkers for PTSD. Design, setting, and participants The analysis was conducted between June to November 2024 using genomic samples and laboratory test results recorded in the Mass General Brigham (MGB) Health System. The analysis included 23,743 European ancestry participants from the nested MGB Biobank study. Exposures The first exposure was polygenic risk score (PRS) for PTSD, calculated using the largest available European ancestry genome-wide association study (GWAS), employing a Bayesian polygenic scoring method. The second exposure was a clinical diagnosis of PTSD, determined by the presence of two or more qualifying PTSD phecodes in the longitudinal electronic health records (EHR). Main outcomes and measures The primary outcomes were the inverse normal quantile transformed, median lab values of 241 laboratory traits with non-zero h 2 SNP estimates. Results Sixteen unique laboratory traits across the cardiometabolic, hematologic, hepatic, and immune systems were implicated in both genomic and phenotypic lab-wide association scans (LabWAS). Two-sample Mendelian randomization analyses provided evidence of potential unidirectional causal effects of PTSD liability on five laboratory traits. Conclusion and relevance These findings demonstrate the potential of a triangulation approach to uncover scalable and clinically relevant biomarkers for PTSD. Key points Question Is genetic liability or diagnosis of PTSD associated with clinical laboratory measures? Findings Among European ancestry participants in the MGB Biobank, we identified 16 unique laboratory traits in cardiometabolic, hematologic, hepatic, and immune systems that were both genetically and phenotypically associated with PTSD, with five markers demonstrating potential unidirectional causal effects of PTSD liability. Meaning Our findings reveal associations between PTSD and laboratory markers across multiple physiological systems, with evidence suggesting possible unidirectional causal effects of PTSD liability on cardiometabolic, hematologic, and hepatic markers.

Year:

2025

Psychiatric disorders display high levels of comorbidity and genetic overlap 1,2 . Genomic methods have shown that even for schizophrenia and bipolar disorder, two disorders long-thought to be etiologically distinct 3 , the majority of genetic signal is shared 4 . Furthermore, recent cross-disorder analyses have uncovered over a hundred pleiotropic loci shared across eight disorders 5 . However, the full scope of shared and disorder-specific genetic basis of psychopathology remains largely uncharted. Here, we address this gap by triangulating across a suite of cutting-edge statistical genetic and functional genomic analyses applied to 14 childhood- and adult-onset psychiatric disorders (1,056,201 cases). Our analyses identify and characterize five underlying genomic factors 6 that explain the majority of the genetic variance of the individual disorders (∼66% on average) and are associated with 268 pleiotropic loci. We observed particularly high levels of polygenic overlap 7 and local genetic correlation 8 and very few disorder-specific loci 9 for two factors defined by: ( i ) schizophrenia and bipolar disorder (“SB factor”), and by ( ii ) major depression, PTSD, and anxiety (“internalizing factor”). At the functional level, we applied multiple methods 10–12 which demonstrated that the shared genetic signal across the SB factor was substantially enriched in genes expressed in excitatory neurons, whereas the internalizing factor was associated with oligodendrocyte biology. By comparison, the genetic signal shared across all 14 disorders was enriched for broad biological processes (e.g., transcriptional regulation). These results indicate increasing differentiation of biological function at different levels of shared cross-disorder risk, from quite general vulnerability to more specific pathways associated with subsets of disorders. These observations may inform a more neurobiologically valid psychiatric nosology and implicate novel targets for therapeutic developments designed to treat commonly occurring comorbid presentations.

Year:

2025

In recent years, significant efforts have been made to improve methods for genomic studies of admixed populations using Local Ancestry Inference (LAI). Accurate LAI is crucial to ensure downstream analyses reflect the genetic ancestry of research participants accurately. Here, we test analytic strategies for LAI to provide guidelines for optimal accuracy, focusing on admixed populations reflective of Latin America’s primary continental ancestries – African (AFR), Amerindigenous (AMR), and European (EUR). Simulating LD-informed admixed haplotypes under a variety of 2 and 3-way admixture models, we implemented a standard LAI pipeline, testing three reference panel compositions to quantify their overall and ancestry-specific accuracy. We examined LAI miscall frequencies and true positive rates (TPR) across simulation models and continental ancestries. AMR tracts have notably reduced LAI accuracy as compared to EUR and AFR tracts in all comparisons, with TPR means for AMR ranging from 88-94%, EUR from 96-99% and AFR 98-99%. When LAI miscalls occurred, they most frequently erroneously called European ancestry in true Amerindigenous sites. Using a reference panel well-matched to the target population, even with a lower sample size, LAI produced true-positive estimates that were not statistically different from a high sample size but mismatched reference, while being more computationally efficient. While directly responsive to admixed Latin American cohort compositions, these trends are broadly useful for informing best practices for LAI across other admixed populations. Our findings reinforce the need for inclusion of more underrepresented populations in sequencing efforts to improve reference panels.

Year:

2024

Collaborators (40)

Jordan Smoller

Professor

Massachusetts General Hospital

UNITED STATES
View details

Naomi Wray

University of Queensland

AUSTRALIA
View details

Stephen V Faraone

Distinguished Professor

SUNY Upstate Medical University

UNITED STATES
View details

G. Bragi Walters

Research Assistant Professor

University of Iceland

ICELAND
View details

Howard Edenberg

Distinguished Professor

Indiana University School of Medicine

UNITED STATES
View details

Matthew Panizzon

Professor

University of Washington

UNITED STATES
View details

Clement C Zai

Associate Professor

University of Toronto

CANADA
View details

Susan Santangelo

Research Professor

Tufts University School of Medicine

UNITED STATES
View details

Ditte Demontis

Aarhus University

DENMARK
View details

Na Cai

Assistant Professor

ETH Zürich

SWITZERLAND
View details

Tian Ge

Broad Institute

UNITED STATES
View details

Andrea Roberts

Principal Research Scientist

Harvard T.H. Chan School of Public Health

UNITED STATES
View details

James Knowles

Distinguished Professor and Executive Director of the HGINJ

Rutgers University - Busch Campus

UNITED STATES
View details

Joanna Biernacka

Associate Professor

Mayo Clinic

UNITED STATES
View details

Andrew Grotzinger

Associate Professor

Memorial University of Newfoundland

CANADA
View details

Benjamin Neale

Associate Professor

Broad Institute

UNITED STATES
View details

Kenneth S. Kendler

Professor

Virginia Commonwealth University

UNITED STATES
View details

John Hettema

Professor

Texas A&M University

UNITED STATES
View details

Phil Lee

Associate Professor

Massachusetts General Hospital

UNITED STATES
View details

Oleksandr Frei

Associate Professor (20%)

University of Oslo

NORWAY
View details

Sandra Sanchez-Roige

Associate Professor

University of California, San Diego

UNITED STATES
View details

Murray Stein

Distinguished Professor

University of California, San Diego

UNITED STATES
View details

Laura Thornton

Research Professor

University of North Carolina

UNITED STATES
View details

Kari Stefansson

Professor

University of Iceland

ICELAND
View details

Elizabeth Atkinson

Assistant Professor

Baylor College of Medicine

UNITED STATES
View details

Joel Gelernter

Professor

Yale University School of Medicine

UNITED STATES
View details

Manuel Mattheisen

Associate Professor

Ludwig-Maximilians-Universität München

GERMANY
View details

Barbara Franke

Head of department

Radboud University Medical Center

NETHERLANDS
View details

Michael Gandal

William & Noreen Hetznecker Associate Professor

University of Pennsylvania

UNITED STATES
View details

Royce Clifford

Research Scientist

UC San Diego Health System

UNITED STATES
View details

Justin D Tubbs

Assistant Professor

Massachusetts General Hospital

UNITED STATES
View details

Josefin Werme

University of Amsterdam

NETHERLANDS
View details

Karen Mitchell

Assistant Professor

Boston University

UNITED STATES
View details

Elliot M. Tucker-Drob

Faculty Research Associate

University of Texas at Austin

UNITED STATES
View details

Ole A. Andreassen

Oslo University Hospital

NORWAY
View details

Irwin Waldman

Professor

Emory University

UNITED STATES
View details

Brandon Coombes

Assistant Professor of Biostatistics

Mayo Clinic

UNITED STATES
View details

Wouter Peyrot

VU medisch centrum

NETHERLANDS
View details

Katherine Jonas

Assistant Professor

Stony Brook University

UNITED STATES
View details

John Nurnberger

Professor/Distinguished Professor

Indiana University School of Medicine

UNITED STATES
View details